Mitigation of sepsis-associated acute kidney injury by thymoquinone via targeting pyroptosis and attenuation of inflammation in C57BL/6 mice

Articles in Press

Document Type : Original Article

Authors

1 Faculty of Medicine, Shahed University, Tehran, Iran

2 Neurophysiology Research Center, Shahed University, Tehran, Iran

10.22038/ijbms.2026.92268.19913

Abstract

Objective(s): Acute kidney injury (AKI) is a severe, life-threatening complication of sepsis that often leads to renal failure. Thymoquinone, the main bioactive component of Nigella sativa, exhibits potent antioxidant and anti-inflammatory effects, protecting heart, liver, and kidney tissues in experimental studies. This study aimed to investigate the protective effects of thymoquinone on lipopolysaccharide (LPS)-induced AKI in mice by assessing oxidative stress, inflammatory mediators, pyroptosis factors, and renal function markers via modulation of oxidative stress and pyroptosis pathways.
Materials and Methods: Thirty-two male C57BL/6 mice (20–25 g) were randomized into four groups: control, LPS, and two LPS groups treated with thymoquinone solubilized in Cremophor (1 or 10 mg/kg). AKI was induced by intraperitoneal injection of LPS (10 mg/kg). After 24 hr, blood samples were collected for blood urea nitrogen (BUN), cystatin C, and serum creatinine assays. Kidney homogenates were analyzed for malondialdehyde (MDA), superoxide dismutase (SOD), nitrite, interleukin-6 (IL-6), nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3 (NLRP3), and caspase-1 levels.
Results: Thymoquinone (10 mg/kg; PO) significantly decreased BUN (P<0.05), cystatin C (P<0.05), and serum creatinine (P<0.05) levels. It also reduced MDA concentration (P<0.05) and increased SOD activity (P<0.05), while nitrite levels remained unchanged. Furthermore, IL-6, NLRP3, and caspase-1 were significantly lower (for all factors, P<0.05) in thymoquinone-treated mice compared to the LPS group.
Conclusion: Thymoquinone effectively attenuates LPS-induced AKI, likely by reducing oxidative stress, inhibiting pyroptosis and inflammation, and enhancing antioxidant defenses.

Keywords

Main Subjects

References

1. Ostermann M, Lumlertgul N, Jeong R, See E, Joannidis M, James M. Acute kidney injury. Lancet 2025; 405:241-256. 
2. Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med 2017; 43:816-828. 
3. Hato T, Dagher PC. Molecular Mechanisms of sepsis-associated acute kidney injury. J Am Soc Nephrol 2025; 36:2259-2268. 
4. Cui Y, Gao H, Han S, Yuan R, He J, Zhuo Y, et al. Oleuropein attenuates lipopolysaccharide-induced acute kidney injury in vitro and in vivo by regulating Toll-like receptor 4 dimerization. Front Pharmacol 2021; 12:617314. 
5. Cao Y, Chen X, Zhu Z, Luo Z, Hao Y, Yang X, et al. STING contributes to lipopolysaccharide-induced tubular cell inflammation and pyroptosis by activating endoplasmic reticulum stress in acute kidney injury. Cell Death Dis 2024; 15:217. 
6. Deng J, Tan W, Luo Q, Lin L, Zheng L, Yang J. Long Non-coding RNA MEG3 promotes renal tubular epithelial cell pyroptosis by regulating the miR-18a-3p/GSDMD pathway in lipopolysaccharide-induced acute kidney injury. Front Physiol 2021; 12:663216. 
7. Zhou Z, Li Q. The role of pyroptosis in the pathogenesis of kidney diseases. Kidney Dis (Basel) 2023; 9:443-458. 
8. Kang HG, Lee HK, Cho KB, Park SI. A review of natural products for prevention of acute kidney injury. Medicina (Kaunas) 2021; 57. 
9. Asaduzzaman Khan M, Tania M, Fu S, Fu J. Thymoquinone, as an anticancer molecule: From basic research to clinical investigation. Oncotarget 2017; 8:51907-51919. 
10. Khan FZ, Mostaid MS, Apu MNH. Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease. Heliyon 2022; 8:e09874. 
11. Althafar ZM, Al-Gabri N, Alnomasy SF. Ameliorative impacts of interleukin 35 or thymoquinone nanoparticles on lipopolysaccharide-induced renal injury in rats. Int Immunopharmacol 2024; 135:112249. 
12. Alenezi SK. The ameliorative effect of thymoquinone on vincristine-induced peripheral neuropathy in mice by modulating cellular oxidative stress and cytokine. Life (Basel) 2022; 13:101. 
13. Shahmohammadi A, Golchoobian R, Mirahmadi SM, Rousta AM, Ansari F, Sharayeli M, et al. Scutellarin alleviates lipopolysaccharide-provoked septic nephrotoxicity via attenuation of inflammatory and oxidative events and mitochondrial dysfunction. Immunopharmacol Immunotoxicol 2023; 45:295-303. 
14. Valenzuela PL, Ruilope LM, Santos-Lozano A, Wilhelm M, Kränkel N, Fiuza-Luces C, et al. Exercise benefits in cardiovascular diseases: From mechanisms to clinical implementation. Eur Heart J 2023; 44:1874-1889. 
15. Perico N, Remuzzi G. Acute kidney injury in low-income and middle-income countries: No longer a death sentence. Lancet Glob Health 2016; 4:e216-217. 
16. Yang Y, Song M, Liu Y, Liu H, Sun L, Peng Y, et al. Renoprotective approaches and strategies in acute kidney injury. Pharmacol Ther 2016; 163:58-73. 
17. Kalakeche R, Hato T, Rhodes G, Dunn KW, El-Achkar TM, Plotkin Z, et al. Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J Am Soc Nephrol 2011; 22:1505-1516. 
18. Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, et al. A unified theory of sepsis-induced acute kidney injury: Inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014; 41:3-11. 
19. Plotnikov EY, Pevzner IB, Zorova LD, Chernikov VP, Prusov AN, Kireev, II, et al. Mitochondrial damage and mitochondria-targeted antioxidant protection in LPS-induced acute kidney injury. Antioxidants (Basel) 2019; 8:176. 
20. Du J, Jiang S, Hu Z, Tang S, Sun Y, He J, et al. Vitamin D receptor activation protects against lipopolysaccharide-induced acute kidney injury through suppression of tubular cell apoptosis. Am J Physiol Renal Physiol 2019; 316:F1068-F1077. 
21. Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis 2019; 10:128. 
22. Sun Q, Scott MJ. Caspase-1 as a multifunctional inflammatory mediator: Noncytokine maturation roles. J Leukoc Biol 2016; 100:961-967. 
23. Li G, Jia J, Ji K, Gong X, Wang R, Zhang X, et al. The neutrophil elastase inhibitor, sivelestat, attenuates sepsis-related kidney injury in rats. Int J Mol Med 2016; 38:767-775. 
24. Yu C, Qi D, Sun JF, Li P, Fan HY. Rhein prevents endotoxin-induced acute kidney injury by inhibiting NF-κB activities. Sci Rep 2015; 5:11822. 
25. Dirkes S. Sepsis and inflammation: Impact on acute kidney injury. Nephrol Nurs J 2013; 40:125-132; 
26. Li Z, Pan H, Yang J, Chen D, Wang Y, Zhang H, et al. Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-κB and MAPK pathways in LPS-induced ALI and inflammation models. Phytomedicine 2023; 108:154545. 
27. Wu QR, Yang H, Zhang HD, Cai YJ, Zheng YX, Fang H, et al. IP3R2-mediated Ca(2+) release promotes LPS-induced cardiomyocyte pyroptosis via the activation of NLRP3/Caspase-1/GSDMD pathway. Cell Death Discov 2024; 10:91. 
28. Zhang X, Su C, Zhao S, Li J, Yu F. Combination therapy of ulinastatin with thrombomodulin alleviates endotoxin (LPS) - induced liver and kidney injury via inhibiting apoptosis, oxidative stress and HMGB1/TLR4/NF-κB pathway. Bioengineered 2022; 13:2951-2970. 
29. Yu YY, Li XQ, Hu WP, Cu SC, Dai JJ, Gao YN, et al. Self-developed NF-κB inhibitor 270 protects against LPS-induced acute kidney injury and lung injury through improving inflammation. Biomed Pharmacother 2022; 147:112615. 
30. Luo RR, Yang J, Sun YL, Zhou BY, Zhou SX, Zhang GX, et al. Dexmedetomidine attenuates ferroptosis by Keap1-Nrf2/HO-1 pathway in LPS-induced acute kidney injury. Naunyn Schmiedebergs Arch Pharmacol 2024; 397:7785-7796. 
31. Guo LP, Liu SX, Yang Q, Liu HY, Xu LL, Hao YH, et al. Effect of Thymoquinone on acute kidney injury induced by sepsis in BALB/c mice. Biomed Res Int 2020; 2020:1594726. 
32. Hannan MA, Zahan MS, Sarker PP, Moni A, Ha H, Uddin MJ. Protective effects of black cumin (Nigella sativa) and its bioactive constituent, thymoquinone against kidney injury: An aspect on pharmacological insights. Int J Mol Sci 2021; 22:9078. 
33. Al Fayi M, Otifi H, Alshyarba M, Dera AA, Rajagopalan P. Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling. J Drug Target 2020; 28:913-922. 
34. Elsherbiny NM, Maysarah NM, El-Sherbiny M, Al-Gayyar MM. Renal protective effects of thymoquinone against sodium nitrite-induced chronic toxicity in rats: Impact on inflammation and apoptosis. Life Sci 2017; 180:1-8. 
35. Hammad FT, Lubbad L. The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat. Int J Physiol Pathophysiol Pharmacol 2016; 8:152-159
36. Mahmood NN, Rashid BM, Abdulla SK, Marouf BH, Hamaamin KS, Othman HH. Effects of zofenopril and thymoquinone in cyclophosphamide-induced urotoxicity and nephrotoxicity in rats; the value of their anti-inflammatory and antioxidant properties. J Inflamm Res 2025; 18:3657-3676. 
37. Hosseini A, Mehri S, Aminifard T, Ghasemzadeh Rahbardar M, Nouripor S, Khajavi Rad A, et al. Renoprotective effect of thymoquinone against rhabdomyolysis-induced acute kidney injury in the rat model. Iran J Basic Med Sci 2024; 27:552-559. 
38. Alsharidah M, Abdel-Moneim A-MH, Alsharidah AS, Mobark MA, Rahmani AH, Shata A, et al. Thymoquinone, but not metformin, protects against gentamicin-induced nephrotoxicity and renal dysfunction in rats. Applied Sciences 2021; 11:3981
39. Sener U, Uygur R, Aktas C, Uygur E, Erboga M, Balkas G, et al. Protective effects of thymoquinone against apoptosis and oxidative stress by arsenic in rat kidney. Ren Fail 2016; 38:117-123. 
40. Faisal Lutfi M, Abdel-Moneim AH, Alsharidah AS, Mobark MA, Abdellatif AAH, Saleem IY, et al. Thymoquinone lowers blood glucose and reduces oxidative stress in a rat model of diabetes. Molecules 2021; 26:2348. 
41. Hofni A, Ali FEM, Ibrahim ARN, Aboubaker EM. Renoprotective effect of thymoquinone against streptozotocin-induced diabetic nephropathy: Role of NOX2 and Nrf2 signals. Curr Mol Pharmacol 2023; 16:905-914. 
42. Kaymak E, Ceylan T, Akın T, Kuloğlu N, Sayan M, Değer N, et al. Effect of thymoquinone on NRF2/NF-kB/MAPK pathway in methotrexate-induced rat testis injury. Iran J Basic Med Sci 2024; 27:1410-1416. 
43. Liu H, Sun Y, Zhang Y, Yang G, Guo L, Zhao Y, et al. Role of Thymoquinone in cardiac damage caused by sepsis from BALB/c mice. Inflammation 2019; 42:516-525. 
44. Elgohary S, Eissa RA, El Tayebi HM. Thymoquinone, a novel multi-strike inhibitor of pro-tumorigenic breast cancer (BC) markers: CALR, NLRP3 pathway and sPD-L1 in PBMCs of HR+ and TNBC patients. Int J Mol Sci 2023; 24:14254. 
45. Pei ZW, Guo Y, Zhu HL, Dong M, Zhang Q, Wang F. Thymoquinone protects against hyperlipidemia-induced cardiac damage in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice via its anti-inflammatory and antipyroptotic effects. Biomed Res Int 2020; 2020:4878704. 
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 26 April 2026

Files

Share

How to cite

Statistics